ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma
暂无分享,去创建一个
V. Paradis | J. Calderaro | B. le Bail | J. Nault | E. Vibert | J. Blanc | C. Guettier | L. Schwarz | A. Laurent | O. Scatton | M. Chirica | F. Cauchy | A. Ferrero | J. Akiba | M. Di Martino | H. Yano | E. Boleslawski | C. Lim | L. di Tommaso | S. Okumura | C. Costentin | L. Barbier | O. Detry | M. Donadon | P. Honoré | S. Langella | Young-Nyun Park | M. Nebbia | R. Rhaiem | R. Brustia | Hyungjin Rhee | É. Audureau
[1] T. Murakami,et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update , 2021, Liver Cancer.
[2] S. Kubo,et al. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma. , 2020, Surgery.
[3] Richard D Riley,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.
[4] S. Rebouissou,et al. Advances in molecular classification and precision oncology in hepatocellular carcinoma. , 2020, Journal of hepatology.
[5] Y. N. Park,et al. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma , 2020, Hepatology.
[6] Tian Yang,et al. Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection. , 2019, Journal of hepatology.
[7] G. Casazza,et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. , 2019, Journal of hepatology.
[8] P. Johnson,et al. Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection". , 2019, Journal of hepatology.
[9] M. García-Fiñana,et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. , 2018, Journal of hepatology.
[10] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[11] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[12] S. Imbeaud,et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. , 2017, Journal of hepatology.
[13] Dong-hao Wu,et al. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1 , 2016, Oncotarget.
[14] A. Luciani,et al. Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features , 2016, Hepatology.
[15] R. D'Agostino,et al. Developing points‐based risk‐scoring systems in the presence of competing risks , 2016, Statistics in medicine.
[16] J. Yun,et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial–mesenchymal transition–independent manner , 2015, Hepatology.
[17] A. Cucchetti,et al. Prognostic factors for hepatocellular carcinoma recurrence. , 2014, World journal of gastroenterology.
[18] Thomas A. Gerds,et al. Concordance for prognostic models with competing risks , 2014, Biostatistics.
[19] S. Imbeaud,et al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. , 2013, Gastroenterology.
[20] Suqing Zhang,et al. Perioperative Allogenenic Blood Transfusion Is Associated with Worse Clinical Outcomes for Hepatocellular Carcinoma: A Meta-Analysis , 2013, PloS one.
[21] Peter Bühlmann,et al. MissForest - non-parametric missing value imputation for mixed-type data , 2011, Bioinform..
[22] G. Tiberio,et al. Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications , 2006, Annals of surgery.
[23] S. Fan,et al. Extended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified? , 2002, Annals of surgery.
[24] S. Fan,et al. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.
[25] H. Toyoda,et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma , 1997, Hepatology.
[26] W. Lau,et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis. , 2016, Journal of hepatology.
[27] P. Hermanek,et al. Residual tumor (R) classification and prognosis. , 1994, Seminars in surgical oncology.